Engineered Drug-Resistant Immunocompetent Cells Enhance Tumor Cell Killing During a Chemotherapy Challenge
Biochemical and Biophysical Research Communications - United States
doi 10.1016/j.bbrc.2009.11.026
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2010
Authors
Publisher
Elsevier BV